Preventive techniques to limit glucocorticoid-induced side effects.
Vittorio
C C
CC
Department of Dermatology, University of Pennsylvania, Philadelphia, USA.
Werth
V P
VP
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D004700:Endocrine System Diseases / Q000139:chemically induced / Q000517:prevention & control; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D001523:Mental Disorders / Q000139:chemically induced / Q000517:prevention & control; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control; D013256:Steroids; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D013256:Steroids